LEASE by and between 3 VDG Owner LLC, a Delaware limited liability company and Fractyl Health, Inc., a Delaware corporationLease • December 14th, 2023 • Fractyl Health, Inc. • Surgical & medical instruments & apparatus
Contract Type FiledDecember 14th, 2023 Company IndustryTHIS LEASE (this “Lease”) is entered into as of August 10, 2022 (the “Execution Date”), by and between 3 VDG Owner LLC, a Delaware limited liability company (“Landlord”), and Fractyl Health, Inc., a Delaware corporation (“Tenant”).
LEASE by and between BMR-ATHENA LP, a Delaware limited partnership and TURNSTONE BIOLOGICS CORP., a Delaware corporationLease • May 15th, 2023 • Turnstone Biologics Corp. • Biological products, (no disgnostic substances)
Contract Type FiledMay 15th, 2023 Company IndustryTHIS LEASE (this “Lease”) is entered into as of this 23rd day of [June], 2021 (the “Execution Date”), by and between BMR-ATHENA LP, a Delaware limited partnership (“Landlord”), and TURNSTONE BIOLOGICS CORP., a Delaware corporation (“Tenant”).
LEASE by and between B9 LS HARRISON & WASHINGTON LLC, a Delaware limited liability company and MONTE ROSA THERAPEUTICS, INC., a Delaware corporationLease • March 29th, 2022 • Monte Rosa Therapeutics, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledMarch 29th, 2022 Company IndustryTHIS LEASE (this “Lease”) is entered into as of this 14th day of December, 2021 (the “Execution Date”), by and between B9 LS HARRISON & WASHINGTON LLC, a Delaware limited liability company with offices located at 4570 Executive Drive, Suite 400, San Diego, California 92121 (“Landlord”), and MONTE ROSA THERAPEUTICS, INC., a Delaware corporation, with offices located at 645 Summer Street, Suite 102, Boston, Massachusetts 02210 (“Tenant”).
LEASE by and between BMR-HAMPSHIRE LLC, a Delaware limited liability company and SURFACE ONCOLOGY, INC., a Delaware corporationLease • October 4th, 2021 • CM Life Sciences III Inc. • Pharmaceutical preparations
Contract Type FiledOctober 4th, 2021 Company IndustryTHIS LEASE (this “Lease”) is entered into as of this 13th day of May, 2016 (the “Execution Date”), by and between BMR-HAMPSHIRE LLC, a Delaware limited liability company (“Landlord”), and SURFACE ONCOLOGY, INC., a Delaware corporation (“Tenant”).
LEASE by and between B9 LS HARRISON & WASHINGTON LLC, a Delaware limited liability company and PYXIS ONCOLOGY, INC., a Delaware corporationLease • October 1st, 2021 • Pyxis Oncology, Inc. • Pharmaceutical preparations
Contract Type FiledOctober 1st, 2021 Company IndustryTHIS LEASE (this “Lease”) is entered into as of this 29th day of September, 2021 (the “Execution Date”), by and between B9 LS HARRISON & WASHINGTON LLC, a Delaware limited liability company (“Landlord”), and PYXIS ONCOLOGY, INC., a Delaware corporation (“Tenant”).
LEASE by and between BMR-MODA SORRENTO LP, a Delaware limited partnership, AS LANDLORD and CUE HEALTH INC., a Delaware corporation, AS TENANTLease • September 1st, 2021 • Cue Health Inc. • Laboratory analytical instruments
Contract Type FiledSeptember 1st, 2021 Company IndustryTHIS LEASE (this “Lease”) is entered into as of this 4th day of December, 2018 (the “Execution Date”), by and between BMR-MODA SORRENTO LP, a Delaware limited partnership (“Landlord”), and CUE HEALTH INC., a Delaware corporation (“Tenant”).
LEASE by and between BMR-325 VASSAR STREET LLC, a Delaware limited liability company and OMEGA THERAPEUTICS, INC. a Delaware corporationLease • July 26th, 2021 • Omega Therapeutics, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledJuly 26th, 2021 Company IndustryTHIS LEASE (this “Lease”) is entered into as of this 30th day of November, 2017 (the “Execution Date”), by and between BMR-325 Vassar Street LLC, a Delaware limited liability company (“Landlord”), and Omega Therapeutics, Inc., a Delaware corporation (“Tenant”).
LEASE by and between BMR-ROAD TO THE CURE LP, a Delaware limited partnership and ERASCA, INC., a Delaware corporationLease • June 25th, 2021 • Erasca, Inc. • Pharmaceutical preparations
Contract Type FiledJune 25th, 2021 Company IndustryTHIS LEASE (this “Lease”) is entered into as of this 27th day of July, 2018 (the “Execution Date”), by and between BMR-ROAD TO THE CURE LP, a Delaware limited partnership (“Landlord”), and ERASCA, INC., a Delaware corporation (“Tenant”).
LEASELease • May 28th, 2021 • Codex DNA, Inc. • Laboratory analytical instruments
Contract Type FiledMay 28th, 2021 Company IndustryTHIS LEASE (this “Lease”) is entered into as of this 04th day of April, 2019 (the “Execution Date”), by and between BMR-WAPLES LP, a Delaware limited partnership (“Landlord”), and SGI-DNA, INC., a Delaware corporation (“Tenant”).
LEASE by and between BMR-ROAD TO THE CURE LP, a Delaware limited partnership and ERASCA, INC., a Delaware corporationLease • May 7th, 2021 • Erasca, Inc. • Pharmaceutical preparations
Contract Type FiledMay 7th, 2021 Company IndustryTHIS LEASE (this “Lease”) is entered into as of this 27th day of July, 2018 (the “Execution Date”), by and between BMR-ROAD TO THE CURE LP, a Delaware limited partnership (“Landlord”), and ERASCA, INC., a Delaware corporation (“Tenant”).
LEASE by and between BMR-MODA SORRENTO LP, a Delaware limited partnership, AS LANDLORD and CUE HEALTH INC., a Delaware corporation, AS TENANTLease • April 19th, 2021 • Cue Health Inc. • Laboratory analytical instruments
Contract Type FiledApril 19th, 2021 Company IndustryTHIS LEASE (this “Lease”) is entered into as of this 4th day of December, 2018 (the “Execution Date”), by and between BMR-MODA SORRENTO LP, a Delaware limited partnership (“Landlord”), and CUE HEALTH INC., a Delaware corporation (“Tenant”).
LEASE by and between BMR-ONE RESEARCH WAY LLC, a Delaware limited liability company and PMV PHARMACEUTICALS, INC., a Delaware corporationLease • March 3rd, 2021 • PMV Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledMarch 3rd, 2021 Company IndustryTHIS LEASE (this “Lease”) is entered into as of this 8th day of January, 2021 (the “Execution Date”), by and between BMR-ONE RESEARCH WAY LLC, a Delaware limited liability company (“Landlord”), and PMV PHARMACEUTICALS, INC., a Delaware corporation (“Tenant”).
LEASE by and between BMR-500 FAIRVIEW AVENUE LLC, a Delaware limited liability company and SILVERBACK THERAPEUTICS, INC., a Delaware corporation 500 Fairview Avenue North, Seattle, WashingtonLease • November 10th, 2020 • Silverback Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 10th, 2020 Company IndustryTHIS LEASE (this “Lease”) “is entered into as of this 8th day of June, 2016 (the “Execution Date”), by and between BMR-500 FAIRVIEW AVENUE LLC, a Delaware limited liability company (“Landlord”), and SILVERBACK THERAPEUTICS, INC., a Delaware corporation (“Tenant”).
LEASE by and between BMR-HAMPSHIRE LLC, a Delaware limited liability company and ONCORUS, INC., a Delaware corporationLease • September 11th, 2020 • Oncorus, Inc. • Pharmaceutical preparations
Contract Type FiledSeptember 11th, 2020 Company IndustryTHIS LEASE (this “Lease”) is entered into as of this 10th day of May, 2016 (the “Execution Date”), by and between BMR-HAMPSHIRE LLC, a Delaware limited liability company (“Landlord”), and ONCORUS, INC., a Delaware corporation (“Tenant”).
LEASE by and between VENTAS BECKLEY, LLC a Delaware limited liability company and GRAYBUG VISION, INC. a Delaware corporationLease • September 4th, 2020 • Graybug Vision, Inc. • Pharmaceutical preparations
Contract Type FiledSeptember 4th, 2020 Company IndustryTHIS LEASE (this “Lease”) is entered into as of this 8 day of October, 2019 (the “Effective Date”), by and between VENTAS BECKLEY, LLC, a Delaware limited liability company (“Landlord”), and GRAYBUG VISION, INC., a Delaware corporation (“Tenant”).
LEASELease • July 10th, 2020 • Zentalis Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledJuly 10th, 2020 Company IndustryTHIS LEASE (this “Lease”) is entered into as of this 12th day of November, 2015 (the “Execution Date”), by and between BMR-ROAD TO THE CURE LP, a Delaware limited partnership (“Landlord”), and ZENO PHARMACEUTICALS, INC., a Delaware corporation (“Tenant”).
LEASE by and between BMR-134 COOLIDGE AVENUE LLC, a Delaware limited liability company and PANDION THERAPEUTICS, INC., a Delaware corporationLease • June 26th, 2020 • Pandion Therapeutics Holdco LLC • Pharmaceutical preparations
Contract Type FiledJune 26th, 2020 Company IndustryTHIS LEASE (this “Lease”) is entered into as of this 6th day of February, 2020 (the “Execution Date”), by and between BMR-134 COOLIDGE AVENUE LLC, a Delaware limited liability company (“Landlord”), and PANDION THERAPEUTICS, INC., a Delaware corporation (“Tenant”).
LEASE by and between BMR-134 COOLIDGE AVENUE LLC, a Delaware limited liability company and PANDION THERAPEUTICS, INC., a Delaware corporationLease • May 22nd, 2020 • Pandion Therapeutics Holdco LLC • Pharmaceutical preparations
Contract Type FiledMay 22nd, 2020 Company IndustryTHIS LEASE (this “Lease”) is entered into as of this 6th day of February, 2020 (the “Execution Date”), by and between BMR-134 COOLIDGE AVENUE LLC, a Delaware limited liability company (“Landlord”), and PANDION THERAPEUTICS, INC., a Delaware corporation (“Tenant”).
LEASE by and between BMR-ROAD TO THE CURE LP, a Delaware limited partnership and ZENO PHARMACEUTICALS, INC., a Delaware corporationLease • March 6th, 2020 • Zentalis Pharmaceuticals, LLC • Pharmaceutical preparations
Contract Type FiledMarch 6th, 2020 Company IndustryTHIS LEASE (this “Lease”) is entered into as of this 12th day of November, 2015 (the “Execution Date”), by and between BMR-ROAD TO THE CURE LP, a Delaware limited partnership (“Landlord”), and ZENO PHARMACEUTICALS, INC., a Delaware corporation (“Tenant”).
LEASE by and between BMR-ROAD TO THE CURE LP, a Delaware limited partnership and ZENO PHARMACEUTICALS, INC., a Delaware corporationLease • February 14th, 2020 • Zentalis Pharmaceuticals, LLC • Pharmaceutical preparations
Contract Type FiledFebruary 14th, 2020 Company IndustryTHIS LEASE (this “Lease”) is entered into as of this 12th day of November, 2015 (the “Execution Date”), by and between BMR-ROAD TO THE CURE LP, a Delaware limited partnership (“Landlord”), and ZENO PHARMACEUTICALS, INC., a Delaware corporation (“Tenant”).
LEASE by and between BMR-134 COOLIDGE AVENUE LLC, a Delaware limited liability company and BLEND THERAPEUTICS, INC. a Delaware corporationLease • December 23rd, 2019 • Organovo Holdings, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledDecember 23rd, 2019 Company IndustryTHIS LEASE (this “Lease”) is entered into as of this 12th day of December, 2011 (the “Execution Date”), by and between BMR-134 COOLIDGE AVENUE LLC, a Delaware limited liability company (“Landlord”), and BLEND THERAPEUTICS, INC. a Delaware corporation (“Tenant”).
LEASE by and between BMR-HAMPSHIRE LLC, a Delaware limited liability company and ONCORUS, INC., a Delaware corporationLease • December 20th, 2019 • Oncorus, Inc. • Pharmaceutical preparations
Contract Type FiledDecember 20th, 2019 Company IndustryTHIS LEASE (this “Lease”) is entered into as of this 10th day of May, 2016 (the “Execution Date”), by and between BMR-HAMPSHIRE LLC, a Delaware limited liability company (“Landlord”), and ONCORUS, INC., a Delaware corporation (“Tenant”).
LEASELease • November 8th, 2019 • Selecta Biosciences Inc • Pharmaceutical preparations
Contract Type FiledNovember 8th, 2019 Company IndustryTHIS LEASE (this “Lease”) is entered into as of this 23rd day of July, 2019 (the “Execution Date”), by and between BRE-BMR Grove LLC, a Delaware limited liability company (“Landlord”), and Selecta Biosciences, Inc., a Delaware corporation (“Tenant”).
LEASE by and between BMR-ROGERS STREET LLC, a Delaware limited liability company and CYCLERION THERAPEUTICS, INC. a Massachusetts corporationLease • April 2nd, 2019 • Cyclerion Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledApril 2nd, 2019 Company IndustryTHIS LEASE (this “Lease”) is entered into as of this 1st day of April, 2019 (the “Execution Date”), by and between BMR-ROGERS STREET LLC, a Delaware limited liability company (“Landlord”), and CYCLERION THERAPEUTICS, INC., a Massachusetts corporation (“Tenant”).
LEASE by and between BMR-SIDNEY RESEARCH CAMPUS LLC, a Delaware limited liability company and GRITSTONE ONCOLOGY, INC. a Delaware corporationLease • July 9th, 2018 • Gritstone Oncology, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledJuly 9th, 2018 Company IndustryTHIS LEASE (this “Lease”) is entered into as of this 11th day of February, 2016 (the “Execution Date”), by and between BMR-Sidney Research Campus LLC, a Delaware limited liability company (“Landlord”), and Gritstone Oncology, Inc., a Delaware corporation (“Tenant”).
LEASE by and between BMR-BAYSHORE BOULEVARD LP, a Delaware limited partnership and UNITY BIOTECHNOLOGY, INC., a Delaware corporationLease • April 5th, 2018 • Unity Biotechnology, Inc. • Pharmaceutical preparations • California
Contract Type FiledApril 5th, 2018 Company Industry JurisdictionTHIS LEASE (this “Lease”) is entered into as of this 13th day of May, 2016 (the “Execution Date”), by and between BMR-BAYSHORE BOULEVARD LP, a Delaware limited partnership (“Landlord”), and UNITY BIOTECHNOLOGY, INC., a Delaware corporation (“Tenant”).
LEASE by and between BMR-ROGERS STREET LLC, a Delaware limited liability company and SYNLOGIC, INC. a Delaware corporationLease • March 20th, 2018 • Synlogic, Inc. • Pharmaceutical preparations
Contract Type FiledMarch 20th, 2018 Company IndustryTHIS LEASE (this “Lease”) is entered into as of this ____ day of [_______], 2017 (the “Execution Date”), by and between BMR-ROGERS STREET LLC, a Delaware limited liability company (“Landlord”), and SYNLOGIC, INC., a Delaware corporation (“Tenant”).
LEASE by and between BMR-PACIFIC RESEARCH CENTER LP, a Delaware limited partnership and SHOTSPOTTER, INC., a Delaware corporation, d/b/a SST, INC.Lease • May 2nd, 2017 • Shotspotter, Inc • Services-prepackaged software
Contract Type FiledMay 2nd, 2017 Company IndustryIN WITNESS WHEREOF, Tenant has executed this Acknowledgment of Term Commencement Date and Term Expiration Date as of the date first written above.
LEASE by and between BMR-PACIFIC RESEARCH CENTER LP, a Delaware limited partnership and SHOTSPOTTER, INC., a Delaware corporation, d/b/a SST, INC.Lease • March 30th, 2017 • Shotspotter, Inc • Services-prepackaged software
Contract Type FiledMarch 30th, 2017 Company IndustryIN WITNESS WHEREOF, Tenant has executed this Acknowledgment of Term Commencement Date and Term Expiration Date as of the date first written above.
LEASE by and between BMR-PACIFIC RESEARCH CENTER LP, a Delaware limited partnership and PROTAGONIST THERAPEUTICS, INC., a Delaware corporationLease • March 7th, 2017 • Protagonist Therapeutics, Inc • Pharmaceutical preparations
Contract Type FiledMarch 7th, 2017 Company IndustryTHIS LEASE (this “Lease”) is entered into as of this 6th day of March, 2017 (the “Execution Date”), by and between BMR-PACIFIC RESEARCH CENTER LP, a Delaware limited partnership (“Landlord”), and PROTAGONIST THERAPEUTICS, INC., a Delaware corporation (“Tenant”).
LEASE by and between BMR-AXIOM LP, a Delaware limited partnership and LA JOLLA PHARMACEUTICAL COMPANY, a California corporationLease • February 23rd, 2017 • La Jolla Pharmaceutical Co • Biological products, (no disgnostic substances)
Contract Type FiledFebruary 23rd, 2017 Company Industry
LEASE by and between WEXFORD-UCSC II, LP, a Delaware limited partnership and SPARK THERAPEUTICS, INC.,Lease • March 14th, 2016 • Spark Therapeutics, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledMarch 14th, 2016 Company IndustryNew Markets Tax Credits: This building/Project was financed in part with a Federal subsidy called New Markets Tax Credits (NMTC). The NMTC Program was established by Congress in 2000 to spur new or increased investments into operating businesses and real estate projects located in low-income communities. Communities benefit from the jobs associated with these investments, as well as greater access to public facilities, goods, and services. In addition, as the communities develop, they become even more attractive to investors, spurring further investments and revitalization.
LEASE by and between BMR-AXIOM LP, a Delaware limited partnership and IGNYTA, INC., a Delaware corporationLease • October 21st, 2015 • Ignyta, Inc. • Pharmaceutical preparations
Contract Type FiledOctober 21st, 2015 Company IndustryTHIS LEASE (this “Lease”) is entered into as of this 16th day of October, 2015 (the “Execution Date”), by and between BMR-AXIOM LP, a Delaware limited partnership (“Landlord”), and IGNYTA, INC., a Delaware corporation (“Tenant”).
LEASE by and between BMR-MEDICAL CENTER DRIVE LLC, a Delaware limited liability company and REGENXBIO INC., a Delaware corporationLease • August 17th, 2015 • REGENXBIO Inc. • Biological products, (no disgnostic substances) • Maryland
Contract Type FiledAugust 17th, 2015 Company Industry JurisdictionTHIS LEASE (this “Lease”) is entered into as of this 6th day of March, 2015 (the “Execution Date”), by and between BMR-MEDICAL CENTER DRIVE LLC, a Delaware limited liability company (“Landlord”), and REGENXBIO INC., a Delaware corporation (“Tenant”).
LEASE by and between BMR-675 WEST KENDALL STREET LLC, a Delaware limited liability company and ALNYLAM PHARMACEUTICALS, INC., a Delaware corporationLease • August 7th, 2015 • Alnylam Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledAugust 7th, 2015 Company IndustryIN WITNESS WHEREOF, Tenant has executed this Acknowledgment of Term Commencement Date and Term Expiration Date as of the date first written above.